Herpes simplex virus causes recurring outbreaks of painful blisters on the skin or mucous membranes, but its effects reach well beyond the sores you can see. After the initial infection, the virus retreats into nerve cells and stays there for life, periodically reactivating to produce new episodes of shedding and, sometimes, symptoms that have nothing to do with blisters. The range of what herpes can do spans from mild, barely noticeable skin irritation all the way to rare but serious complications involving the eyes, brain, and newborns.
How the Virus Settles In
Whether you pick up HSV-1 (the type most associated with cold sores) or HSV-2 (typically linked to genital herpes), the basic playbook is the same. The virus enters through mucous membranes or small breaks in the skin, replicates in surface cells, and then travels along nerve fibers into nearby clusters of nerve cell bodies called ganglia. Once there, it essentially goes quiet, tucking its DNA inside neurons and entering a dormant state called latency. This is not a temporary hiding phase. The virus persists in those neurons indefinitely, and your immune system cannot clear it.
From latency, the virus can wake up and travel back down the nerve fibers to the skin surface, producing a new round of viral particles and sometimes visible sores. This cycle between neurons and peripheral tissues is a defining feature of all alphaherpesviruses.
1PubMed Central. Herpesvirus transport to the nervous system and back againWhat a First Outbreak Looks Like
A true first episode of herpes tends to be the worst one. If you’ve never been exposed to either type before, your immune system has no pre-existing antibodies to blunt the attack. The sores are often more numerous and more painful, and they take longer to heal. Flu-like symptoms, swollen lymph nodes, and fever are common companions. A first episode in someone who already carries one HSV type and then picks up the other tends to be milder, because cross-reactive antibodies offer partial protection.
2PubMed. First-episode, recurrent, and asymptomatic herpes simplex infectionsRecurrent outbreaks are usually shorter and less severe. They often begin with a tingling or burning sensation at the site where sores are about to appear, a warning called the prodrome. Over time, many people find that outbreaks become less frequent, though the virus never disappears entirely.
Triggers and Reactivation
The virus does not reactivate on a predictable schedule. A variety of stimuli can kick it out of dormancy, and researchers have identified both shared and distinct biological pathways behind different triggers.
3PubMed Central. Strength in diversity: Understanding the pathways to herpes simplex virus reactivation Commonly reported triggers include illness, emotional stress, fatigue, sun exposure, menstruation, and physical trauma to the area.
The stress connection has biological backing. In lab studies using neuronal cultures, the stress hormone epinephrine significantly boosted HSV-1 replication in certain types of nerve cells.
4PubMed Central. Stress Hormones Epinephrine and Corticosterone Selectively Modulate Herpes Simplex Virus 1 (HSV-1) and HSV-2 Productive Infections in Adult Sympathetic, but Not Sensory, Neurons More dramatic disruptions to the nervous system can also play a role. Traumatic brain injury, for instance, has emerged as a potential trigger for HSV-1 reactivation because it disrupts the neuronal stability and local immune surveillance that keep the virus in check.
5PubMed Central. HSV-1 reactivation as an emergent property of neuronal stress: implications for traumatic brain injuryAsymptomatic Shedding and Why It Matters
One of the most consequential things herpes does is shed virus without producing visible symptoms. In a study that tracked daily genital swabs, people with symptomatic HSV-2 shed virus on about 20% of days, while those who had never noticed symptoms still shed on roughly 10% of days.
6PubMed Central. Genital Shedding of Herpes Simplex Virus Among Symptomatic and Asymptomatic Persons with HSV-2 Infection The amount of virus released during these silent episodes was essentially the same in both groups, meaning an asymptomatic person can be just as infectious during a shedding episode as someone who gets frequent sores.
Modeling work confirms that most transmissions happen during prolonged shedding episodes with high viral loads, many of which never produce a visible ulcer or produce one so small it goes unnoticed.
7PubMed Central. Herpes simplex virus-2 transmission probability estimates based on quantity of viral shedding This is the main reason herpes spreads so effectively: a large share of transmission happens when neither partner realizes the virus is active.
Effects on the Eyes
HSV-1 keratitis, an infection of the cornea, is a leading cause of infectious blindness in industrialized countries.
8PubMed. Human herpes simplex virus keratitis: the pathogenesis revisited The virus can affect any layer of the cornea, from the surface epithelium down to the deeper stroma and inner endothelium. The real damage comes not just from the virus itself but from the immune response it provokes. Repeated bouts of herpes stromal keratitis trigger inflammation that leads to scarring, new blood vessel growth into normally clear corneal tissue, and loss of corneal nerve function.
9PubMed Central. Pathogenesis of herpes simplex keratitis: The host cell response and ocular surface sequelae to infection and inflammation Even with effective antiviral treatment available, recurrent episodes continue to cause progressive corneal clouding in some patients, eventually requiring a corneal transplant to restore vision.
When Herpes Reaches the Brain
Herpes simplex encephalitis is rare, but it is the most feared complication of HSV infection. The virus can cross into the central nervous system and target the limbic system, including the hippocampus and amygdala, regions critical for memory and emotion. The resulting inflammation and tissue damage can produce seizures, confusion, personality changes, and even psychosis.
10Radiology Case Reports. Unmasking herpes encephalitis masquerading as acute psychosis via neuroimagingEven with antiviral treatment, the long-term outlook for survivors can be rough. Some patients develop severe brain swelling that requires emergency surgery, and the condition can be fatal in those cases.
11PubMed Central. Long-term outcome of severe herpes simplex encephalitis: a population-based observational study Among survivors, cognitive impairment is common. Research has linked the degree of nerve cell damage during the acute illness, as well as the development of autoimmune antibodies against brain receptors afterward, with worse cognitive scores at follow-up.
12PubMed. Cerebrospinal fluid biomarkers of brain injury, inflammation and synaptic autoimmunity predict long-term neurocognitive outcome in herpes simplex encephalitisThe Alzheimer’s Connection
A more speculative but increasingly studied long-term effect involves the possible link between HSV-1 and Alzheimer’s disease. The hypothesis is that repeated viral reactivation in the brain, even at low levels, might contribute to neurodegenerative changes over decades. Lab work has shown that HSV-1 infection can alter the splicing of the Tau protein, a molecule central to Alzheimer’s pathology, leading to forms of Tau that clump together abnormally.
13PubMed Central. Herpes simplex virus-1 infection alters microtubule-associated protein Tau splicing and promotes Tau pathology in neural models of Alzheimer’s diseaseA separate line of evidence points to HSV-1’s manipulation of a protein called cofilin-1, which regulates the structural framework of nerve cells. Dysfunction of cofilin-1 has been observed in most Alzheimer’s patients, and in animal models, restoring its function improved cognitive performance. The overlap between what HSV-1 does to cofilin-1 during infection and what goes wrong with it in Alzheimer’s brains is suggestive, though far from proof of causation.
14PubMed. Dysregulation of cofilin-1 activity-the missing link between herpes simplex virus type-1 infection and Alzheimer’s disease The field is still debating whether HSV-1 is a genuine contributing cause or merely one of many insults that nudge vulnerable brains toward degeneration.
Herpes in Newborns
Neonatal herpes is uncommon but devastating. About 85% of cases are acquired during delivery, when the baby passes through an infected birth canal.
15PubMed Central. Maternal-Fetal Implications of Herpes Virus Infection: An Updated Review The disease is classified into three forms based on severity. Skin, eye, and mouth disease is the mildest, confined to those surfaces. Central nervous system disease involves the brain and can present as seizures, lethargy, poor feeding, and a bulging soft spot on the skull, typically appearing around two weeks after birth. Disseminated disease, the most dangerous form, spreads to the lungs, liver, adrenal glands, and brain. Disseminated disease carries the highest mortality, while CNS disease carries the highest rate of lasting neurological damage.
16NeoReviews. Neonatal Herpes Simplex Virus InfectionPrompt treatment with intravenous antiviral medication is critical to reducing death and neurological consequences in all forms of neonatal herpes.
Nerve Pain and Radiculopathy
Beyond the well-known blisters, HSV-2 can cause problems in the nerve roots themselves. Autopsy studies have found dormant HSV-2 in roughly 40% of sacral nerve clusters, and only about 5% of those individuals had ever been diagnosed with genital herpes during their lives.
17JAMA Neurology. Neurological Complications of Herpes Simplex Virus Type 2 Infection When the virus reactivates in lumbar or sacral nerve roots, it can produce shooting pain, tingling, urinary retention, constipation, and leg weakness. These episodes of radiculopathy are often recurrent and can be mistaken for other conditions like sciatica or spinal disc problems.
Skin Complications Beyond Blisters
In people with weakened skin barriers, herpes can behave very differently from the typical small cluster of sores. Eczema herpeticum occurs when HSV spreads widely across skin already damaged by atopic dermatitis, producing widespread blistering that can become a medical emergency if bacteria enter the mix.
18PubMed Central. Eczema herpeticum: A medical emergency in patients with atopic dermatitisHerpes can also trigger an immune-mediated skin reaction called erythema multiforme, which produces target-shaped red lesions on the hands, feet, and sometimes inside the mouth. This is not a direct viral infection of the skin but rather the immune system overreacting to viral material. In susceptible people, each herpes recurrence can spark a new round of erythema multiforme.
19PubMed Central. Herpes associated erythema multiformeImmunocompromised individuals face a different set of challenges. In people on immunosuppressive drugs, HSV outbreaks can appear in unusual locations, take atypical forms, and be severe enough to require intensive care. These presentations are easily misdiagnosed because they don’t look like textbook herpes.
20PubMed Central. Atypical Presentation of Herpes Simplex Virus Infection in an Immunocompromised PatientHow Herpes Interacts with HIV
HSV-2 and HIV have a well-documented synergy. Active genital herpes brings large numbers of activated immune cells to the genital area, and those same cells are the primary targets for HIV. A meta-analysis found that people with existing HSV-2 infection in the general population were nearly three times as likely to acquire HIV. Among people who had recently caught HSV-2, the risk was nearly five times higher.
21PubMed Central. Effect of HSV-2 infection on subsequent HIV acquisition: an updated systematic review and meta-analysis The mucosal disruption from herpes sores provides a direct entry point for HIV, while the influx of vulnerable immune cells creates a welcoming environment for the virus even in the absence of visible ulcers.
The Psychological Toll
For many people, the emotional weight of a herpes diagnosis is heavier than the physical symptoms. A prospective cohort study found that people with recurrent genital HSV-2 had significantly higher rates of depression and anxiety compared to uninfected controls, with roughly 29% meeting criteria for depression versus 8% among controls. Stigma scores and sexual distress remained elevated throughout the 12-month follow-up. Having five or more outbreaks per year, poor adherence to antiviral medication, female sex, being in a relationship where your partner is uninfected, and lack of social support all independently predicted worse psychological outcomes.
22PubMed. Beyond the outbreaks: The enduring psychological burden of recurrent symptomatic genital herpes – A prospective cohort studyResearch on the psychology of herpes stigma suggests a self-reinforcing cycle: negative feelings and poor coping lead to more frequent outbreaks, and more frequent outbreaks make the stigma feel more salient, deepening distress.
23PubMed. The psychological impact of genital herpes stigma Among younger women with genital herpes, perceived stigma, how a person copes with the diagnosis, and access to support (including from online communities) accounted for roughly two-thirds of the variation in herpes-related quality of life scores, dwarfing the physical symptoms themselves as predictors of well-being.
24PubMed Central. Psychological adjustment among women living with genital herpesAntivirals and Their Limits
The mainstay of herpes treatment is acyclovir and its derivatives (valacyclovir, famciclovir), which work by blocking the viral enzyme responsible for copying its DNA.
25PubMed. Acyclovir: mechanism of action, pharmacokinetics, safety and clinical applications These drugs shorten outbreaks, reduce their severity, and when taken daily as suppressive therapy, cut the frequency of recurrences and lower the risk of transmission. What they do not do is reach the latent virus hiding inside nerve cells. Once you stop taking the medication, the virus remains capable of reactivating.
A newer class of drugs targeting the viral helicase-primase complex is in development. Structural studies have revealed how these inhibitors lock the viral replication machinery in an inactive state, and single-molecule experiments show they cause the machinery to stall during DNA unwinding.
26PubMed Central. Mechanisms of HSV-1 helicase-primase inhibition and replication fork complex assembly Pritelivir, the most advanced compound in this class, has shown promise in clinical trials, particularly for immunocompromised patients who develop resistance to acyclovir.
The Vaccine Problem
Despite decades of effort, there is no approved vaccine against herpes simplex virus, either to prevent infection or to treat it therapeutically.
27PubMed Central. Developments in Vaccination for Herpes Simplex Virus The challenge is unique. HSV has evolved sophisticated ways to evade the immune system, and the latency mechanism means that even a strong immune response cannot eliminate the virus once it is established. Several prophylactic approaches have generated protective immunity in animal models but failed in human trials.
28PubMed Central. Prophylactic vaccine strategies and the potential of therapeutic vaccines against herpes simplex virusThe fact that most people with HSV-1 carry the virus without serious problems suggests the immune system can control the infection even if it cannot erase it. This observation has shifted some research interest toward therapeutic vaccines that would reduce outbreaks and shedding in people already infected, rather than solely trying to prevent new infections. Multiple candidates are in preclinical and clinical stages, but none are close to approval.
Gene Editing as a Potential Cure
The most exciting frontier in herpes research is the possibility of actually eliminating the latent virus from nerve cells. Several research groups have used gene-editing tools delivered by viral vectors to cut the dormant HSV DNA in animal models. In mouse models of both oral and genital HSV-1 infection, a combination of specially designed enzymes called meganucleases eliminated over 90% of latent viral DNA, and up to 97% in the genital infection model.
29PubMed Central. Gene editing and elimination of latent herpes simplex virus in vivo Shedding of virus was also reduced in treated animals.
30Nature Communications. Gene editing for latent herpes simplex virus infection reduces viral load and shedding in vivoA separate approach using CRISPR-Cas9, delivered intravenously by a single dose of an AAV9 vector, eliminated viral shedding in 92% of treated eyes in a rabbit model of HSV-1 keratitis and reduced HSV-1 DNA in the nerve ganglia.
31PubMed Central. CRISPR-Cas9-mediated genome editing delivered by a single AAV9 vector inhibits HSV-1 reactivation in a latent rabbit keratitis model These results are from animal studies, and the jump to safe, effective treatment in humans involves substantial hurdles, including delivering the editing machinery to the right nerve cells without off-target effects. But the trajectory of the research is genuinely promising. A first-in-human trial for one meganuclease-based approach has been announced, making this the closest anyone has come to a functional cure.
Testing Pitfalls
Diagnosing herpes sounds straightforward but has real limitations, especially when relying on blood tests. Antibody-based tests detect past exposure rather than current infection, and their accuracy varies. In one study comparing antibody tests to direct viral detection, the accuracy of HSV-2 antibody testing for confirmed HSV-2 infection was only about 38%, and combined antibody testing for both types was accurate just 35% of the time.
32PubMed Central. Comparison of the Accuracy of HSV1 and HSV2 Antibody Tests with PCR in the Diagnosis of Recurrent Genital Herpes False positives are a well-known issue, particularly with older test formats that struggle to distinguish between HSV-1 and HSV-2 antibodies. Newer assays using specific viral protein fragments perform better, with sensitivity reaching 100% and specificity around 98% in optimized conditions.
33PubMed. Performance characteristics of a glycoprotein G based oligopeptide (peptide 55) and two different methods using the complete glycoprotein as assays for detection of anti-HSV-2 antibodies in human seraThe gold standard for diagnosing an active outbreak remains direct testing of a lesion, either by viral culture or, increasingly, by PCR. If you have a sore, getting it swabbed while it is fresh gives the most reliable result. Blood tests are useful for understanding whether you carry the virus but can mislead when used in isolation, particularly if the result is a low-positive value.
An Ancient Partnership
Herpes simplex is not a modern nuisance. Evolutionary analysis suggests HSV-1 has been co-evolving with our lineage since before modern humans existed, diverging alongside its host species over millions of years. HSV-2 appears to have jumped to an ancestral human species from the ancestor of modern chimpanzees roughly 1.6 million years ago.
34PubMed Central. Evolutionary origins of human herpes simplex viruses 1 and 2 That deep history helps explain why the virus is so adept at hiding from the immune system: it has had an extraordinarily long time to refine its tricks. It also puts the difficulty of creating a vaccine into perspective. We are trying to outmaneuver a pathogen that has been perfecting evasion strategies across geological time scales.